Annexin Pharmaceuticals AB (ANNX)

Currency in SEK
29.8000
-1.0000(-3.25%)
Closed·
ANNX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ANNX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
28.200032.0000
52 wk Range
22.100085.9236
Key Statistics
Prev. Close
30.8
Open
31.2
Day's Range
28.2-32
52 wk Range
22.1-85.9236
Volume
18.58K
Average Volume (3m)
14.69K
1-Year Change
-58.93%
Book Value / Share
6.42
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ANNX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Annexin Pharmaceuticals AB Company Profile

Annexin Pharmaceuticals AB (publ), a biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases. It develops ANXV, a human recombinant protein. The company offers Annexin A5 to protect and repair blood vessels and counteract inflammation. Annexin Pharmaceuticals AB (publ) was founded in 2014 and is based in Stockholm, Sweden.

Compare ANNX to Peers and Sector

Metrics to compare
ANNX
Peers
Sector
Relationship
P/E Ratio
−5.3x0.0x−0.5x
PEG Ratio
−0.080.000.00
Price/Book
4.6x0.0x2.6x
Price / LTM Sales
-0.0x3.2x
Upside (Analyst Target)
224.7%0.0%41.2%
Fair Value Upside
Unlock0.0%6.2%Unlock

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-1.48 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ANNX Income Statement

FAQ

What Stock Exchange Does Annexin Pharma Trade On?

Annexin Pharma is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Annexin Pharma?

The stock symbol for Annexin Pharma is "ANNX."

What Is the Annexin Pharma Market Cap?

As of today, Annexin Pharma market cap is 210.36M.

What Is Annexin Pharma's Earnings Per Share (TTM)?

The Annexin Pharma EPS (TTM) is -6.91.

From a Technical Analysis Perspective, Is ANNX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Annexin Pharma Stock Split?

Annexin Pharma has split 3 times.

How Many Employees Does Annexin Pharma Have?

Annexin Pharma has 4 employees.

What is the current trading status of Annexin Pharma (ANNX)?

As of 29 Jul 2025, Annexin Pharma (ANNX) is trading at a price of 29.80, with a previous close of 30.80. The stock has fluctuated within a day range of 28.20 to 32.00, while its 52-week range spans from 22.10 to 85.92.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.